What Changed
Price Move History
- Daily moves over 5%
- 0 21 sessions, September 18, 2026 to November 2, 2026
- Largest daily move
- -0.5% close of October 29, 2026
- 1-month change
- +0% closing prices, October 2, 2026 to November 2, 2026
Company Description
Leader's Advantage Acquisition Units (NASDAQ: LEDRU) is classified in the shell companies industry within the Financial Services sector.
LEDRU has gained 0.0% over the past month. The last closing price was $9.97.
This page collects what Stock Titan holds for LEDRU, including price data, latest news, SEC filings, and short interest trends.
Stock Performance
Leader's Advantage Acquisition Units (LEDRU) closed at $9.97 on November 2, 2026. Over the past month, the price has gained 0.0%.
LEDRU Metrics & Rankings
Price returns through November 2, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Leader's Advantage Acquisition Units has 1 recent news article. Key topics include IPO, offering. View all LEDRU news →
SEC Filings
Leader's Advantage Acquisition Units has filed 10 recent SEC filings, including 6 Form 4, 2 Form 8-K, 2 Form SCHEDULE 13G. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all LEDRU SEC filings →
Short Interest History
Short interest in Leader's Advantage Acquisition Units (LEDRU) currently stands at 11.5 thousand shares, down 32.2% from the previous reporting period. Since September 2026, short interest has decreased by 32.2%.
Days to Cover History
Days to cover for Leader's Advantage Acquisition Units (LEDRU) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.
LEDRU Company Profile & Sector Positioning
Leader's Advantage Acquisition Units (LEDRU) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the NASDAQ.
Investors comparing LEDRU often look at related companies in the same sector, including Drugs Made In America Acquisition II Corp. (DMII), EQV Ventures Acquisition Corp. II (EVAC), Bain Capital GSS Investment Corp. (BCSS), Cantor Equity Partners IV, Inc. (CEPF), and Churchill Capital Corp XII (CXII). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate LEDRU's relative position within its industry.